Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Clinical Imaging|August 3, 2014
Isolated intracerebral light chain deposition disease: novel imaging and pathologic findingsJohn-Paul J Yu, David M Wilson, Edward F Chang, et al.British Journal of Haematology|June 11, 2009
Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantationAnuj Mahindra, Brian Bolwell, Ronald Sobecks, et al.Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
The treatment of multiple myeloma patients not eligible for asctPaul Richardson, Jacob Laubach, Anuj Mahindra, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphomaAnuj Mahindra, Brian Bolwell, Ronald Sobecks, et al.Ebiomedicine|July 3, 2015
Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple MyelomaElizabeth O'Donnell, Anuj Mahindra, Andrew J Yee, et al.European Journal of Haematology|October 14, 2011
The Medical Research Council Myeloma IX trial: the impact on treatment paradigmsPaul G Richardson, Jacob P Laubach, Robert L Schlossman, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2011
Management of relapsed and relapsed/refractory multiple myelomaJacob P Laubach, Constantine S Mitsiades, Anuj Mahindra, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
Novel therapies in the treatment of multiple myelomaJacob P Laubach, Constantine S Mitsiades, Anuj Mahindra, et al.Molecular Cancer Therapeutics|August 31, 2014
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myelomaDiana Cirstea, Loredana Santo, Teru Hideshima, et al.Clinicoeconomics and Outcomes Research : CEOR|September 18, 2023
Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain AmyloidosisMorie Gertz, Rafat Abonour, Sarah N Gibbs, et al.Pageof 3